Copyright Reports & Markets. All rights reserved.

Global Eszopiclone API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Eszopiclone API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Eszopiclone API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Eszopiclone Tablets
    • 1.4.3 Others
  • 1.5 Global Eszopiclone API Market Size & Forecast
    • 1.5.1 Global Eszopiclone API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Eszopiclone API Sales Quantity (2020-2031)
    • 1.5.3 Global Eszopiclone API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Dr. Reddy’s Laboratories Ltd.
    • 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
    • 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
    • 2.1.3 Dr. Reddy’s Laboratories Ltd. Eszopiclone API Product and Services
    • 2.1.4 Dr. Reddy’s Laboratories Ltd. Eszopiclone API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
  • 2.2 Farmak A.S
    • 2.2.1 Farmak A.S Details
    • 2.2.2 Farmak A.S Major Business
    • 2.2.3 Farmak A.S Eszopiclone API Product and Services
    • 2.2.4 Farmak A.S Eszopiclone API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Farmak A.S Recent Developments/Updates
  • 2.3 Teva API
    • 2.3.1 Teva API Details
    • 2.3.2 Teva API Major Business
    • 2.3.3 Teva API Eszopiclone API Product and Services
    • 2.3.4 Teva API Eszopiclone API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Teva API Recent Developments/Updates
  • 2.4 Symed Labs Limited
    • 2.4.1 Symed Labs Limited Details
    • 2.4.2 Symed Labs Limited Major Business
    • 2.4.3 Symed Labs Limited Eszopiclone API Product and Services
    • 2.4.4 Symed Labs Limited Eszopiclone API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Symed Labs Limited Recent Developments/Updates
  • 2.5 Glenmark Pharmaceuticals
    • 2.5.1 Glenmark Pharmaceuticals Details
    • 2.5.2 Glenmark Pharmaceuticals Major Business
    • 2.5.3 Glenmark Pharmaceuticals Eszopiclone API Product and Services
    • 2.5.4 Glenmark Pharmaceuticals Eszopiclone API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.6 Centaur Pharmaceuticals
    • 2.6.1 Centaur Pharmaceuticals Details
    • 2.6.2 Centaur Pharmaceuticals Major Business
    • 2.6.3 Centaur Pharmaceuticals Eszopiclone API Product and Services
    • 2.6.4 Centaur Pharmaceuticals Eszopiclone API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Centaur Pharmaceuticals Recent Developments/Updates
  • 2.7 Orchid Chemicals & Pharmaceuticals
    • 2.7.1 Orchid Chemicals & Pharmaceuticals Details
    • 2.7.2 Orchid Chemicals & Pharmaceuticals Major Business
    • 2.7.3 Orchid Chemicals & Pharmaceuticals Eszopiclone API Product and Services
    • 2.7.4 Orchid Chemicals & Pharmaceuticals Eszopiclone API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Orchid Chemicals & Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Eszopiclone API by Manufacturer

  • 3.1 Global Eszopiclone API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Eszopiclone API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Eszopiclone API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Eszopiclone API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Eszopiclone API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Eszopiclone API Manufacturer Market Share in 2024
  • 3.5 Eszopiclone API Market: Overall Company Footprint Analysis
    • 3.5.1 Eszopiclone API Market: Region Footprint
    • 3.5.2 Eszopiclone API Market: Company Product Type Footprint
    • 3.5.3 Eszopiclone API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Eszopiclone API Market Size by Region
    • 4.1.1 Global Eszopiclone API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Eszopiclone API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Eszopiclone API Average Price by Region (2020-2031)
  • 4.2 North America Eszopiclone API Consumption Value (2020-2031)
  • 4.3 Europe Eszopiclone API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Eszopiclone API Consumption Value (2020-2031)
  • 4.5 South America Eszopiclone API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Eszopiclone API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Eszopiclone API Sales Quantity by Type (2020-2031)
  • 5.2 Global Eszopiclone API Consumption Value by Type (2020-2031)
  • 5.3 Global Eszopiclone API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Eszopiclone API Sales Quantity by Application (2020-2031)
  • 6.2 Global Eszopiclone API Consumption Value by Application (2020-2031)
  • 6.3 Global Eszopiclone API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Eszopiclone API Sales Quantity by Type (2020-2031)
  • 7.2 North America Eszopiclone API Sales Quantity by Application (2020-2031)
  • 7.3 North America Eszopiclone API Market Size by Country
    • 7.3.1 North America Eszopiclone API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Eszopiclone API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Eszopiclone API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Eszopiclone API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Eszopiclone API Market Size by Country
    • 8.3.1 Europe Eszopiclone API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Eszopiclone API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Eszopiclone API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Eszopiclone API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Eszopiclone API Market Size by Region
    • 9.3.1 Asia-Pacific Eszopiclone API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Eszopiclone API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Eszopiclone API Sales Quantity by Type (2020-2031)
  • 10.2 South America Eszopiclone API Sales Quantity by Application (2020-2031)
  • 10.3 South America Eszopiclone API Market Size by Country
    • 10.3.1 South America Eszopiclone API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Eszopiclone API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Eszopiclone API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Eszopiclone API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Eszopiclone API Market Size by Country
    • 11.3.1 Middle East & Africa Eszopiclone API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Eszopiclone API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Eszopiclone API Market Drivers
  • 12.2 Eszopiclone API Market Restraints
  • 12.3 Eszopiclone API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Eszopiclone API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Eszopiclone API
  • 13.3 Eszopiclone API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Eszopiclone API Typical Distributors
  • 14.3 Eszopiclone API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Eszopiclone API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Eszopiclone is a nonbenzodiazepine, cyclopyrrolone and active stereoisomer of zopiclone with hypnotic and sedative activity and without significant anxiolytic activity. Although the exact mechanism of action remains to be fully elucidated, eszopiclone is able to bind to and activate the omega-1 subtype of the alpha subunit of the gamma-aminobutyric acid-benzodiazepine GABA receptor complex (GABA-A), a chloride ionophore complex in the central nervous system (CNS). This leads to the opening of chloride channels, causing hyperpolarization, inhibition of neuronal firing, and enhancement of the inhibitory effect of GABA. This eventually leads to a hypnotic effect and allows for an induction of sleep.
    This report is a detailed and comprehensive analysis for global Eszopiclone API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Eszopiclone API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Eszopiclone API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Eszopiclone API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Eszopiclone API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Eszopiclone API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Eszopiclone API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Farmak A.S, Teva API, Symed Labs Limited, Glenmark Pharmaceuticals, Centaur Pharmaceuticals, Orchid Chemicals & Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Eszopiclone API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥98%
    Purity<98%
    Market segment by Application
    Eszopiclone Tablets
    Others
    Major players covered
    Dr. Reddy’s Laboratories Ltd.
    Farmak A.S
    Teva API
    Symed Labs Limited
    Glenmark Pharmaceuticals
    Centaur Pharmaceuticals
    Orchid Chemicals & Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Eszopiclone API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Eszopiclone API, with price, sales quantity, revenue, and global market share of Eszopiclone API from 2020 to 2025.
    Chapter 3, the Eszopiclone API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Eszopiclone API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Eszopiclone API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Eszopiclone API.
    Chapter 14 and 15, to describe Eszopiclone API sales channel, distributors, customers, research findings and conclusion.

    Buy now